Drug Shortage Report for FUROSEMIDE INJECTION USP
| Report ID | 239042 |
| Drug Identification Number | 02461404 |
| Brand name | FUROSEMIDE INJECTION USP |
| Common or Proper name | FUROSEMIDE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FUROSEMIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 25 VIALS X 2 ML |
| ATC code | C03CA |
| ATC description | HIGH-CEILING DIURETICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-10-01 |
| Actual start date | |
| Estimated end date | 2024-10-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-02 |
| Company comments | Inventory remains at McKesson. Contract coverage is in place. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-10-02 | English | Compare |
| v2 | 2024-10-01 | French | Compare |
| v1 | 2024-10-01 | English | Compare |
Showing 1 to 3 of 3